Inventor · disambiguated record
Waleed M. Haso
Also filed as: HASO WALEED · HASO WALEED M
6 granted patents·7 pending applications·20 citations·filing 2016–2025
81Inventor score
Files withLENTIGEN TECH INC9KITE PHARMA INC3THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY DEPT OF HEALTH AND HUMAN SERVICES1
Top patents by PatentIndex Score
13 records- 0195US11208455B2Compositions and methods for treating cancer with DuoCARsLENTIGEN TECH INC·Filed 2019·Granted Dec 28, 2021·6 cites·8 claims
- 0295US10689431B2Compositions and methods for treating cancer with DuoCARsLENTIGEN TECH INC·Filed 2018·Granted Jun 23, 2020·8 cites·9 claims
- 0389US11453712B2Compositions and methods for treating cancer with DuoCARsLENTIGEN TECH INC·Filed 2017·Granted Sep 27, 2022·2 cites·8 claims
- 0487US2024043497A1Compositions and Methods for Treating Cancer with DuoCARsLENTIGEN TECH INC·Filed 2023·Application pending·0 cites
- 0587US2025367291A1Compositions and Methods for Treating Cancer with DuoCARsLENTIGEN TECH INC·Filed 2025·Application pending·0 cites
- 0686US11802142B2Compositions and methods for treating cancer with DuoCARsLENTIGEN TECH INC·Filed 2020·Granted Oct 31, 2023·1 cites·7 claims
- 0786US2024025962A1Compositions and methods for treating cancer with duocarsLENTIGEN TECH INC·Filed 2023·Application pending·0 cites
- 0884US10738116B2Dual specific anti-CD22-anti-CD19 chimeric antigen receptorsTHE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY DEPT OF HEALTH AND HUMAN SERVICES·Filed 2016·Granted Aug 11, 2020·3 cites·24 claims
- 0982US2022281946A1Compositions and Methods for Treating Cancer with DuoCARsLENTIGEN TECH INC·Filed 2022·Application pending·0 cites
- 1081US12365718B2Compositions and methods for treating cancer with DuoCARsLENTIGEN TECH INC·Filed 2021·Granted Jul 22, 2025·0 cites·8 claims
- 1164US2023392119A1Compositions and methods for preparing engineered lymphocytes for cell therapyKITE PHARMA INC·Filed 2023·Application pending·0 cites
- 1260US2023027004A1Closed-system and method for autologous and allogeneic cell therapy manufacturingKITE PHARMA INC·Filed 2022·Application pending·0 cites
- 1355US2025375480A1Methods for Generating Engineered LymphocytesKITE PHARMA INC·Filed 2025·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Waleed M. Haso files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →